8 April 2020 – collaboration
The company has announced that it has entered a collaboration with Cytiva (formerly GE Healthcare Life Sciences) to develop and manufacture a rapid test for Covid-19. This has created significant interest in the shares which have performed well of late but clearly this could be an exciting development for the company and the shares are a SPECULATIVE BUY.